XML 26 R6.htm IDEA: XBRL DOCUMENT v3.8.0.1
CONSOLIDATED STATEMENTS OF EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Preferred Stock
Common Stock
Capital Surplus
Undivided Profits
Accumulated Other Comprehensive Income/(Loss)
[1]
Noncontrolling Interest
Beginning balance (shares) at Dec. 31, 2014     234,220        
Beginning balance at Dec. 31, 2014 $ 2,581,590 $ 95,624 $ 146,387 $ 1,380,809 $ 851,585 $ (188,246) $ 295,431
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income/(loss) 97,313       85,879   11,434
Other comprehensive income/(loss): (25,946)         (25,946)  
Comprehensive income/(loss) 71,367       85,879 (25,946) 11,434
Cash dividends declared:              
Preferred stock (6,200)       (6,200)    
Common stock (56,961)       (56,961)    
Common stock repurchased (shares) [2]     (2,277)        
Common stock repurchased [2] (32,648)   $ (1,423) (31,225)      
Common stock issued for:              
Stock options and restricted stock - equity awards (shares)     1,550        
Stock options and restricted stock - equity awards 6,929   $ 969 5,960      
Equity issued for acquisition (shares)     5,094        
Equity issued for acquisition 72,791   $ 3,184 69,607      
Tax benefit/(benefit reversal) - stock based compensation expense 356     356      
Stock-based compensation expense 13,796     13,796      
Dividends declared - noncontrolling interest of subsidiary preferred stock (11,434)           (11,434)
Ending balance (shares) at Dec. 31, 2015     238,587        
Ending balance at Dec. 31, 2015 2,639,586 95,624 $ 149,117 1,439,303 874,303 (214,192) 295,431
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income/(loss) 238,511       227,046   11,465
Other comprehensive income/(loss): (33,462)         (33,462)  
Comprehensive income/(loss) 205,049       227,046 (33,462) 11,465
Cash dividends declared:              
Preferred stock (6,200)       (6,200)    
Common stock (66,160)       (66,160)    
Common stock repurchased (shares) [2]     (7,653)        
Common stock repurchased [2] (97,396)   $ (4,783) (92,613)      
Common stock issued for:              
Stock options and restricted stock - equity awards (shares)     2,690        
Stock options and restricted stock - equity awards 22,521   $ 1,681 20,840      
Tax benefit/(benefit reversal) - stock based compensation expense 1,613     1,613      
Stock-based compensation expense 17,536     17,536      
Dividends declared - noncontrolling interest of subsidiary preferred stock (11,465)           (11,465)
Other       (43) 43    
Ending balance (shares) at Dec. 31, 2016     233,624        
Ending balance at Dec. 31, 2016 2,705,084 95,624 $ 146,015 1,386,636 1,029,032 (247,654) 295,431
Ending balance, as adjusted at Dec. 31, 2016 2,705,084 95,624 $ 146,015 1,386,866 1,028,802 (247,654) 295,431
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Adjustment to reflect adoption of ASU 2018-02       230 (230)    
Net income/(loss) 176,980       165,515   11,465
Other comprehensive income/(loss): (17,625)         (17,625)  
Comprehensive income/(loss) 159,355       165,515 (17,625) 11,465
Cash dividends declared:              
Preferred stock (6,200)       (6,200)    
Common stock (85,174)       (85,174)    
Common stock repurchased (shares)     (297)        
Common stock repurchased (5,554)   $ (185) (5,369)      
Common stock issued for:              
Stock options and restricted stock - equity awards (shares)     1,107        
Stock options and restricted stock - equity awards 6,092   $ 692 5,400      
Equity issued for acquisition (shares)     92,302        
Equity issued for acquisition 1,797,723   $ 57,689 1,740,034      
Stock-based compensation expense 20,627     20,627      
Dividends declared - noncontrolling interest of subsidiary preferred stock (11,465)           (11,465)
Other       55 (55)    
Ending balance (shares) at Dec. 31, 2017     326,736        
Ending balance at Dec. 31, 2017 4,580,488 95,624 $ 204,211 3,147,613 1,102,888 (265,279) 295,431
Ending balance, as adjusted at Dec. 31, 2017 $ 4,580,488 $ 95,624 $ 204,211 $ 3,147,613 1,160,434 (322,825) $ 295,431
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Adjustment to reflect adoption of ASU 2018-02         $ 57,546 $ (57,546)  
[1] Due to the nature of the preferred stock issued by FHN and its subsidiaries, all components of Other comprehensive income/(loss) have been attributed solely to FHN as the controlling interest holder.
[2] 2016 and 2015 include $93.5 million and $28.4 million, respectfully, repurchased under share repurchase programs.